Prosecution Insights
Last updated: October 25, 2026

Mueting Raasch Group

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

119 pending office actions • 52 clients • 109 examiners • 74 art units • 0 of 119 (0%) have an AI response strategy ready • 137 patents granted in the last 365 days

Analysis

MUETING RAASCH GROUP has 122 pending office actions in Biotechnology & Pharmaceuticals, supported by 4748 career applications. This combination reflects an active practice with a substantial prosecution record in its stated technology area.

The resolved allowance rate is 85.21%, while the average is 3.67 office actions per allowance. Read together, these measures indicate that resolved matters frequently reach allowance, while an allowance is associated with multiple office-action responses on average.

For practitioners, the profile supports evaluating both outcome likelihood and expected prosecution effort. The pending workload also makes current docket management relevant when assessing capacity and responsiveness.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=4748 apps, methodology: how we score firms)

85.2%
Allowance Rate
n=4748
+0.75σ
Allowance Rate (norm)
n=4748
3.7
OAs to Allowance
n=2409
-0.09σ
OAs to Allow (norm)
n=2409
1154 days
Time to Allowance
n=2409
+7.0pp
Interview Lift
n=4748
28.4%
RCE Rate
n=4748
4.7%
Appeal Rate
n=4748

Rejection Performance (% of received rejections ultimately overcome)

79.6%
§101 Overcome
n=230
78.1%
§102 Overcome
n=977
78.7%
§103 Overcome
n=1634
80.7%
§112 Overcome
n=1324

Specialization & Scale

A61K, C12N, A61P
Top CPC Subclasses
18%
Top-3 CPC Share
n=4748
11
Practitioners
n=4748
431.6
Apps / Practitioner
n=4748

Portfolio Summary

119
Total Pending OAs
80
Non-Final OAs
33
Final Rejections
6
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 29 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

16
Overdue
1
Due this week
6
Due this month
3
Due in next 60 days
3
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 29 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (16)Due ≤ 7 days (1)Due ≤ 30 days (6)Due ≤ 60 days (3)Due later (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

66
Hard (55%)
42
Medium (35%)
11
Easy (9%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only3 (3%)
§101 + other7 (6%)
§103 only31 (26%)
§102 only2 (2%)
§112 only9 (8%)
Double-patenting only2 (2%)
Double-patenting + other9 (8%)
Multi-statute (no §101)56 (47%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

81
Life Sciences
68% of docket
4
Information Tech
3% of docket
2
Communications
2% of docket
3
Semiconductors
3% of docket
27
Mechanical / Eng
23% of docket
2
Business / Other
2% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

1,190 h
Manual time on pending OAs
238 h
Time saved (low, 20%)
416 h
Time saved (mid, 35%)
10.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
CULBERT, COURTNEY GUENTHER 4 27.8% +4.3%
DEZENDORF, MORGAN FAITH 3 26.7% +50.0%
SAIDHA, TEKCHAND 2 82.9% +14.0%
NGUYEN, PHU HOANG 2 66.0% +19.6%
SCHNEIDER, THOMAS FRANK 2 47.4% +37.2%
FULTON, MICHAEL TIMOTHY 2 71.4% +6.3%
EFTA, ALEX B 2 59.9% +25.3%
CORDAS, EMILY ANN 1 50.9% +57.4%
MACCRATE, NICOLE PAIGE 1 57.0% +22.1%
PRANGE, SHARON M 1 54.2% +46.8%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18687169 FLAVIN-DEPENDENT OXIDASES HAVING CANNABINOID SYNTHASE ACTIVITY SAIDHA, TEKCHAND —

Hard Cases (70)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18214183 PLANT EXTRACTS WITH ANTI-DIABETIC AND OTHER USEFUL ACTIVITIES ABRAHAM, AMJAD A 134d overdue
17622149 METHOD FOR ESTABLISHING AN INDIVIDUAL PHYSICAL ACTIVITY PROGRAM FOR A SUBJECT FOR REDUCING AN INDIVIDUAL RISK OF THE SUBJECT FOR DEVELOPING A CARDIOVASCULAR DISEASE VANN-OJUEKAIYE, KENDRA RAYCHELL 132d overdue
18233659 ORAL ACTIVE AGENT DELIVERY SYSTEM FOR ANIMALS AND METHOD MEYERS, ELIZABETH ANNE 74d overdue
18414671 WALKING BOOT INSERT FOR WOUND CARE LEWIS, KIM M 72d overdue
18913014 SYSTEMS FOR DETERMINING POLLINATION ILLUMINATION PATTERNS AND ASSISTING POLLINATION IN CONTROLLED ENVIRONMENT AGRICULTURE AND RELATED METHODS MUDD, HENRY HOOPER 42d overdue
18109954 PIGMENTED PASSIVE RADIATIVE COOLING COATING CHEN, VIVIAN 17d overdue
18035052 APPARATUS FOR EXTRACORPOREAL TREATMENT OF BLOOD AND PROCESS OF CALCULATING SET FLOW RATES IN A MEDICAL APPARATUS FOR EXTRACORPOREAL TREATMENT OF BLOOD DAKKAK, JIHAD 10d overdue
18280386 STORAGE DEVICE AND METHOD FOR PRODUCING A COMPONENT FROM A DUROPLASTIC TOWPREG SEMI-FINISHED PRODUCT PAGE, HANA C 2d overdue

Interview Candidates (14)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18704240 Untitled CORDAS, EMILY ANN —
19547777 REAR-FACING POULTRY CLAW SYSTEM AND METHOD MACCRATE, NICOLE PAIGE —
19376206 CUSTOM 3-D ORTHOTIC DEVICE PRANGE, SHARON M —
18721990 IMPROVED HEPARAN SULFATE AND METHODS OF MAKING THE SAME SAIDHA, TEKCHAND —
18715867 METHOD FOR MANUFACTURING A VENTILATION ZONE IN AN AEROSOL-GENERATING ARTICLE NGUYEN, PHU HOANG —
18702535 CARTRIDGE FOR INDUCTIVELY HEATED AEROSOL-GENERATING DEVICE DEZENDORF, MORGAN FAITH —
18687483 AEROSOL-GENERATING SYSTEM WITH MOUTHPIECE HAVING SENSORIAL MEDIA DEZENDORF, MORGAN FAITH —
18687169 FLAVIN-DEPENDENT OXIDASES HAVING CANNABINOID SYNTHASE ACTIVITY SAIDHA, TEKCHAND —

Client Portfolio (52 clients)

View all 52 →

Top Art Units

Art UnitApps
174713
17557
17454
36423
16633
37813
16533
16553
37322
16132

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18704240 Untitled Mayo Foundation for Medical Education and Research CORDAS, EMILY ANN §102§103§112Other Non-Final OA — Pending
19547777 REAR-FACING POULTRY CLAW SYSTEM AND METHOD Nova-Tech Engineering, LLC MACCRATE, NICOLE PAIGE 3642 §102§103§112 Non-Final OA — Pending Feb 24, 2026
19376206 CUSTOM 3-D ORTHOTIC DEVICE Footpact, LLC PRANGE, SHARON M 3732 §102§103Other Non-Final OA — Pending Oct 31, 2025
19326385 ENGINEERED GENETIC INCOMPATIBILITY IN PLANTS Regents Of The University Of Minnesota SHEN, YANXIN NMN 1663 §102§103§112 Non-Final OA — Pending Sep 11, 2025
19270144 FORMING APPARATUS AND METHOD FOR FORMING A CONTINUOUS TUBULAR ROD Philip Morris Products, S.A. SHUTTY, DAVID G 3731 §103§112 Non-Final OA — Pending Jul 15, 2025
19221229 PHOTOELECTRIC SENSOR BORESIGHTING IMPROVEMENT Banner Engineering Corp. CARLSON, JOSHUA MICHAEL 2877 §102§103Other Non-Final OA — Pending May 28, 2025
19173368 SKINNED DOOR PANELS WITH REPLACEMENT BOTTOM RAILS Andersen Corporation AUBREY, BETH A 3633 §103§112 Non-Final OA — Pending Apr 08, 2025
19072200 DC-DC CONVERTER WITH PARALLEL SWITCHES AND CONTROL METHOD THEREOF Ablerex Electronics Co., Ltd. PEREZ, BRYAN REYNALDO 2838 §102§103 Non-Final OA — Pending Mar 06, 2025
19108593 SHRIMP SORTING SYSTEMS AND METHODS Nova-Tech Engineering, LLC KUMAR, KALYANAVENKA K 3653 §103§112 Non-Final OA — Pending Mar 04, 2025
19045041 RETRACTABLE SCREEN ASSEMBLIES AND METHODS Andersen Corporation REPHANN, JUSTIN B 3634 §102§103 Non-Final OA — Pending Feb 04, 2025
19101186 INTEGRATED REACTOR, AND CHARGING AND REFUELING SYSTEM AND METHOD Shanghai Nuclear Engineering Research & Design Institute Co., Ltd. WASIL, DANIEL D 3646 §103§112 Non-Final OA — Pending Feb 04, 2025
19039517 IMPLEMENTS FOR DISPLACING GROUND MATERIAL Claussen Technology, LLC TRAN, JULIA C 3671 §102§103§112Other Non-Final OA — Pending Jan 28, 2025
18996039 DEVICE FOR DETECTING PARTICLES BY MEANS OF LENSLESS IMAGING Horiba Abx SAS ORANGE, DAVID BENJAMIN 2663 §101 Non-Final OA — Pending Jan 17, 2025
18974051 EXTRACORPOREAL BLOOD TREATMENT FLOW RATE ADJUSTMENT Gambro Lundia AB SHIBEROU, MAHELET 2171 DP Non-Final OA — Pending Dec 09, 2024
18941057 OUTER SHELL WITH SPACER PADS FOR FIREFIGHTER PROTECTIVE GARMENTS AND FIREFIGHTER PROTECTIVE GARMENTS INCLUDING THE SAME Innotex Inc. HOEY, ALISSA L 3732 §102§103§112 Final Rejection 9d Pending Nov 08, 2024
18919754 AEROSOL-GENERATING ARTICLE, DEVICE AND SYSTEM FOR USE WITH A PLURALITY OF AEROSOL-FORMING SUBSTRATES Philip Morris Products, S.A. MCKANE, ELIZABETH L 3991 §102§103§112 Non-Final OA 8d Pending Oct 18, 2024
18916866 SILICA-COATED STIMULUS-RESPONSIVE POLYMERIC NANOPARTICLES Regents Of The University Of Minnesota PATEL, RONAK C 1788 §103 Non-Final OA — Pending Oct 16, 2024
18915826 METHODS FOR GENERATING AND USING ORGANOIDS AND TISSUE THEREIN Regents Of The University Of Minnesota MOLOYE, TITILAYO 1632 DP Non-Final OA — Pending Oct 15, 2024
18913014 SYSTEMS FOR DETERMINING POLLINATION ILLUMINATION PATTERNS AND ASSISTING POLLINATION IN CONTROLLED ENVIRONMENT AGRICULTURE AND RELATED METHODS Sollum Technologies Inc. MUDD, HENRY HOOPER 3642 §102§103 Final Rejection 42d overdue Pending Oct 11, 2024
18852585 INTELLIGENT MACHINE AUTOMATED CONTROL FOR PRODUCTION LINES Philip Morris Products, S.A. NORTON, JENNIFER L 2117 §112 Non-Final OA — Pending Sep 30, 2024
18898146 ORALLY DISINTEGRATING TABLET COMPRISING AMORPHOUS SOLID DISPERSION OF NILOTINIB AND IN VITRO CHARACTERIZATION THEREOF Nanocopoeia, LLC PHAN, DOAN THI-THUC 1613 §102§103§112DP Non-Final OA — Pending Sep 26, 2024
18846326 LIVE MYCOPLASMA SYNOVIAE VACCINE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. DEVI, SARVAMANGALA 1645 §101§102§112 Non-Final OA — Pending Sep 12, 2024
18781410 BALLISTICALLY LAUNCED PART-CARRYING APPARATUS Product Development Associates, Inc. TOPOLSKI, MAGDALENA 3642 §102§103§112 Non-Final OA — Pending Jul 23, 2024
18775389 SYSTEM AND METHOD TO FACILITATE DETERMINING PERSONALIZED EFFECTIVENESS OR EFFICACY OF A SUBSTANCE Itrial.Me Inc. WEBB, JESSICA MARIE 3683 §101§112 Final Rejection — Pending Jul 17, 2024
18768438 TRUNK AND LEG COMPRESSION GARMENT SYSTEMS Tactile Systems Technology, Inc. BALLER, KELSEY E 3785 §102§103§112 Non-Final OA — Pending Jul 10, 2024
18727846 MEASUREMENT DEVICE AND PROCESS FOR AN AEROSOL GENERATING DEVICE LIFECYCLE TESTING ARRANGEMENT Philip Morris Products, S.A. DIYAN, OLUWATOSIN OLUWATUMININ 1755 §103§112 Non-Final OA — Pending Jul 10, 2024
18760681 INLINE MUFFLER AND POSITIVE AIRWAY PRESSURE THERAPY APPARATUS INCLUDING SAME Somnetics International, Inc. JANG, JAEICK 3785 §102 Non-Final OA — Pending Jul 01, 2024
18751964 APPARATUS FOR COMBUSTION OF SYNTHETIC GASES DERIVING FROM TREATMENT OF ORGANIC MATERIAL, PLANT AND PROCESS FOR TREATMENT OF ORGANIC MATERIAL Bioforcetech Corporation BASICHAS, ALFRED 3762 §102§112 Non-Final OA — Pending Jun 24, 2024
18722857 DIE-HOLDING CYLINDER FOR A LAMINATE DIE-CUTTING MACHINE Comercial Industrial Maquinaria Carton Ondulado, S.L. RILEY, JONATHAN G 3724 §103 Final Rejection 56d overdue Pending Jun 21, 2024
18748562 ENCAPSULATED BIOFILM COMPOSITIONS AND METHODS Regents Of The University Of Minnesota ABDEL LATIF, MAHMOUD MOTAZ 1773 §103 Non-Final OA — Pending Jun 20, 2024
18722045 AQUEOUS MELATONIN FORMULATION Agb-Pharma AB WELLS, LAUREN QUINLAN 1622 §102§103§112 Non-Final OA — Pending Jun 20, 2024
18722260 APPARATUS FOR EXTRACORPOREAL BLOOD TREATMENT Gambro Lundia AB KALIHER, HANS CHRISTIAN 3781 §112 Non-Final OA — Pending Jun 20, 2024
18721990 IMPROVED HEPARAN SULFATE AND METHODS OF MAKING THE SAME UNIVERSITY OF COPENHAGEN SAIDHA, TEKCHAND 1652 §102§112 Non-Final OA — Pending Jun 20, 2024
18739113 UFMYLATION INHIBITION TO TARGET TAUOPATHY IN HUMAN NEURONS Cornell University MARTIN, PAUL C 1653 §102§103§112 Non-Final OA — Pending Jun 10, 2024
18715867 METHOD FOR MANUFACTURING A VENTILATION ZONE IN AN AEROSOL-GENERATING ARTICLE Philip Morris Products, S.A. NGUYEN, PHU HOANG 1747 §112 Non-Final OA — Pending Jun 03, 2024
18715334 AEROSOL-GENERATING ARTICLE HAVING AN AIR CHANNELLING ELEMENT WITH INNER AND OUTER AIR PASSAGEWAYS Philip Morris Products, S.A. DYE, ROBERT C 3619 §103§112 Non-Final OA — Pending May 31, 2024
18712066 AEROSOL-GENERATING ARTICLE HAVING A GROOVED AIR CHANNELLING ELEMENT Philip Morris Products, S.A. NNABUGWU, HANNAH CHINWE 1747 §103§112 Non-Final OA — Pending May 21, 2024
18667481 SYSTEMS AND METHODS FOR TREATING STORMWATER WITH ANAMMOX BACTERIA Regents Of The University Of Minnesota VARMA, AKASH K 1773 §103§112 Non-Final OA — Pending May 17, 2024
18664874 PLANT EXTRACTS WITH ANTI-DIABETIC AND OTHER USEFUL ACTIVITIES Housey Pharmaceutical Research Laboratories, LLC CAIN, JENNIFER LYNN 1655 §102§112DP Non-Final OA — Pending May 15, 2024
18709363 OZONE SPRAY METHODS Seegrow Solutions Limited CONLEY, SEAN EVERETT 1799 §102§103 Non-Final OA — Pending May 10, 2024
18708411 COMPOSITIONS AND METHODS FOR TRANSCRIPTIONAL ACTIVATION Regents Of The University Of Minnesota STEPHENS, REBECCA JOHANNA 1663 §103§112DP Non-Final OA — Pending May 08, 2024
18705216 A METHOD FOR TREATING TOBACCO MATERIAL AND TREATED TOBACCO MATERIAL Philip Morris Products, S.A. CULBERT, COURTNEY GUENTHER 1747 §101§102§103§112 Non-Final OA — Pending Apr 26, 2024
18704816 SAMPLE COLLECTION SYSTEM AND ELUENT DELIVERY ELEMENT FOR THE SAME 3M Company SODERQUIST, ARLEN 1797 §103 Non-Final OA — Pending Apr 25, 2024
18704248 ONCOLYTIC VIROTHERAPY COMPOSITIONS AND METHODS UNM RAINFOREST INNOVATIONS WANG, RUIXUE 1672 §102§103§112 Non-Final OA — Pending Apr 24, 2024
18702535 CARTRIDGE FOR INDUCTIVELY HEATED AEROSOL-GENERATING DEVICE Philip Morris Products, S.A. DEZENDORF, MORGAN FAITH 1755 §102§103§112 Non-Final OA — Pending Apr 18, 2024
18700830 AEROSOL-GENERATING ARTICLE FOR INDUCTIVELY HEATED DEVICE Philip Morris Products, S.A. GRAY, LINDA LAMEY 1745 §102§103 Final Rejection — Pending Apr 12, 2024
18700605 BACTERIOPHAGE PREPARATIONS AND METHODS OF USE The United States Department of Veterans Affairs ALAM, DANYAL HASSAN 1672 §102§103§112Other Non-Final OA — Pending Apr 11, 2024
18695490 ANTIMICROBIAL COMPOUNDS AND THE METHODS OF USE Middle Tennessee State University KIM, SEONG JONG 1621 §102§103§112 Non-Final OA — Pending Mar 26, 2024
18691642 TWO COMPARTMENT FACE MASK 3M Company TU, AURELIE H 3791 §102§103 Non-Final OA — Pending Mar 13, 2024
18691611 USE OF LECTINS TO DETERMINE MAMMAGLOBIN-A GLYCOFORMS IN BREAST CANCER Glycanostics S.R.O. TRAN, CHAU NGUYEN BICH 1677 §101§102§103DP Non-Final OA — Pending Mar 13, 2024

View all 119 →

Managing Mueting Raasch Group's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Mueting Raasch Group's patent allowance rate?

85.2% of resolved applications prosecuted by Mueting Raasch Group were allowed, across 4,748 applications in USPTO records.

How many office actions does Mueting Raasch Group average before allowance?

3.67 office actions per allowed application on average.

How many pending office actions does Mueting Raasch Group have?

119 pending office actions as of October 2026, for 52 clients, before 109 examiners in 74 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month